RossRKPaganini-HillAMackTMArthurMHendersonBE.Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet1981; i: 858–60.
2.
Paganini-HillARossRHendersonB.Postmenopausal oestrogen treatment and stroke: A prospective study. BMJ1988; 297: 579–82.
3.
StuddJSawasMWatsonNGarnettTFogelmanICooperD.The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants. Am J Obstet Gynecol1990; 163: 1474–9.
4.
StuddJWWAndersonHMMontgomeryJC.Selection of patients – kind and duration of treatment. In: GreenblattRB, ed. A modern approach to the perimenopausal years. Berlin: Walter de Gruyter, 1986:129–40.
5.
GarnettTMitchellAStuddJ.Patterns of referral to a menopause clinic. J Roy Soc Med1991; 84: 128–30.
6.
StuddJ.Complications of hormone replacement therapy in postmenopausal women. J Roy Soc Med1992; 85: 376–8.
7.
StevensonJCLeesBDevonportMCustMPGangerKF.Determinants of bone density in normal women: Risk factors for future osteoporosis. BMJ1989; 298: 924–8.
8.
HendersonAFStuddJWW.Oestrogen replacement therapy by percutaneous implantation following hysterectomy for endometriosis. Brit J Obstet Gynaecol1993 (in press).
9.
MagosABrewsterESinghRO'DowdTBrincatMStuddJWW.The effects of norethisterone in postmenopausal women on oestrogen therapy, a model for pre-menstrual syndrome. Br J Obstet Gynaecol1986; 93: 1290–9.